SCHEMBL7370491

SCHEMBL7370491

COc1ccc(C=NO)c(Cl)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.43
TSHR P16473 1/20 0.43
KDM4E B2RXH2 4/20 0.42
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
CA12 O43570 1/20 0.41
POLB P06746 2/20 0.41
HTT P42858 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
RAB9A P51151 3/20 0.40
GAA P10253 2/20 0.40
NPC1 O15118 4/20 0.40
NFKB1 P19838 3/20 0.40
NFKB2 Q00653 3/20 0.40
RELA Q04206 3/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TLR2 O60603 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8731826 1.00 HPGD (0.43) HPGDTSHRKDM4EKMT2AL3MBTL1
SCHEMBL4946232 0.83 POLB (0.57) HPGDTSHRKDM4EKMT2AL3MBTL1
SCHEMBL4946236 0.83 POLB (0.57) HPGDTSHRKDM4EKMT2AL3MBTL1
SCHEMBL1299161 0.79 ERN1 (0.58) ALDH1A1TLR2ERN1TLR1TLR6
SCHEMBL20150808 0.78 KMT2A (0.44) HPGDTSHRKDM4EKMT2AL3MBTL1
SCHEMBL20148160 0.78 KMT2A (0.44) HPGDTSHRKDM4EKMT2AL3MBTL1
SCHEMBL20797186 0.77 HPGD (0.53) HPGDTSHRKMT2AL3MBTL1CA12
SCHEMBL20797185 0.77 HPGD (0.53) HPGDTSHRKMT2AL3MBTL1CA12
SCHEMBL17550790 0.75 CA12 (0.70) HPGDTSHRKDM4EKMT2AL3MBTL1
SCHEMBL6822725 0.75 CA12 (0.70) HPGDTSHRKDM4EKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed